Disc Medicine, Inc. business relationships
Companies named in Disc Medicine, Inc.’s 10-K filed 2026-02-26, and public companies whose annual reports name Disc Medicine, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 12 / 100 Top 2% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Disc Medicine, Inc.’s annual report 4
“In May 2021, we licensed exclusive worldwide rights to develop and commercialize bitopertin from Roche.” SEC filing
“See "Business - Collaborations and License Agreement" for more information regarding our license agreements with Roche, AbbVie and Mabwell.” SEC filing
“DISC-0974 is the lead product candidate in our iron homeostasis portfolio and was licensed from AbbVie Deutschland GmbH & Co. KG, or AbbVie.” SEC filing
“License Agreement with Oak Bay Biosciences, Inc. ("OBB")” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.